alexa Update In Malignant Hyperthermia | 6835
ISSN: 2161-1076

Surgery: Current Research
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Update in Malignant Hyperthermia

International Conference and Exhibition on Surgery, Anesthesia & Trichology

Sheila Riazi

Accepted Abstracts: Surgery Curr Res

DOI: 10.4172/2161-1076.S1.010

Malignant Hyperthermia (MH) is a pharamacogenetic disorder of skeletal muscle cells. At risk patients (MHS) would show potentially fatal hypermetabolic reaction in response to volatile anesthetic, and/or succinylcholine. This update explores the epidemiology of MH, discusses the role of calcium and intracellular proteins involved in the MH crisis, explains clinical characteristics based on recent literature, and describes the latest findings in genetic, and physiologic diagnostic testing of this disorder. In addition, this update will explore other related myopathies, such as central core disease, and an anesthetic approach for these patients are discussed in details. The author will share her latest research with regards to clinical epidemiology, as well as genetics of MH.
Sheila Riazi has completed her MSc in molecular biology at University of Toronto. Following completion of her residency in Anesthesia at University of Toronto, she completed her fellowship in regional anesthesia. She is currently a staff anesthesiologist at Toronto Western Hospital, and she is also the director of the only Canadian center for malignant hyperthermia diagnosis, and research. She is an affiliate scientist at Toronto General Research Institute. Her research focus is both in clinical and genetic aspects of malignant hyperthermia.
Leave Your Message 24x7